SCHEDULE: Dimensional Fund Advisors Reports 5.3% Stake in Emergent BioSolutions

Dimensional Fund Advisors LP has disclosed a beneficial ownership of 5.3% of Emergent BioSolutions Inc.'s common stock as of March 31, 2026.

Summary

• Dimensional Fund Advisors LP (DFA) has filed a Schedule 13G, indicating beneficial ownership of 2,757,158 shares of Emergent BioSolutions Inc. common stock.
• This ownership stake represents 5.3% of the total class of securities.
• DFA acts as an investment adviser and manager for various investment companies and commingled funds.
• The shares reported are owned by these funds, and DFA disclaims beneficial ownership.
• The filing is made under Rule 13d-1(b) of the Securities Exchange Act of 1934.
• The date of the event requiring this filing is March 31, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership by an investment manager and does not contain operational or financial performance updates.

Positives

• Dimensional Fund Advisors LP, a significant investment management firm, holds a notable stake in Emergent BioSolutions Inc.
• The filing indicates that the shares are held in the ordinary course of business and not for the purpose of influencing control.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to ownership disclosure.

Management Comments

• Dimensional Fund Advisors LP disclaims beneficial ownership of the reported securities.
• All securities reported are owned by the Funds for which Dimensional acts as investment advisor, sub-adviser, or manager.
• The filing of this Schedule 13G shall not be construed as an admission that the reporting person or any of its affiliates is the beneficial owner of any securities covered by this Schedule 13G for any other purposes than Section 13(d) of the Securities Exchange Act of 1934.
• The securities referred to were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing by Dimensional Fund Advisors LP signifies a substantial institutional investment in Emergent BioSolutions Inc., indicating confidence from a major asset manager in the company's prospects or valuation. Such filings are common for large investment firms accumulating significant stakes in publicly traded companies.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a reputable investment firm like Dimensional Fund Advisors LP may be viewed positively by other shareholders, potentially indicating institutional confidence in the company.

Key Dates

Keywords

Emergent BioSolutions Inc, Dimensional Fund Advisors LP, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Securities Exchange Act of 1934